Cardiologia

Considerações cardiovasculares perioperatórias antes de cirurgia não cardíaca eletiva em pacientes com histórico de Covid-19.

17 Jan, 2022 | 13:16h

Perioperative Cardiovascular Considerations Prior to Elective Noncardiac Surgery in Patients With a History of COVID-19 – JAMA Surgery

Conteúdos relacionados:

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

BJS commission on surgery and perioperative care post-COVID-19.

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

---

Em um registro prospectivo de implante de valva aórtica transcateter (transcatheter aortic valve implantation – TAVI), os desfechos de 5 anos mostraram que pacientes com regurgitação paravalvular leve tiveram risco aumentado de mortalidade.

17 Jan, 2022 | 13:04h

Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation – EuroIntervention (link para o resumo – $ para o texto completo)

---

Top 10 | Os principais estudos de 2021 que fizeram a diferença na prática clínica cardiológica.

17 Jan, 2022 | 13:03h

Feature | The Top Ten: Key Trials in 2021 Making a Difference in Clinical Practice – American College of Cardiology

---

Revisão sistemática | Em pacientes com claudicação intermitente, propionil-L-carnitina pode melhorar a distância de caminhada em comparação ao placebo (moderada certeza geral de evidência).

17 Jan, 2022 | 12:47h

Propionyl‐L‐carnitine for intermittent claudication – Cochrane Library

Resumo: Propionyl-L-carnitine for intermittent claudication – Cochrane Library

---

O ano de 2021 na medicina cardiovascular: doença cardíaca valvar.

13 Jan, 2022 | 20:59h

The year in cardiovascular medicine 2021: valvular heart disease – European Heart Journal

---

O ano de 2021 na medicina cardiovascular: diabetes e doenças metabólicas.

13 Jan, 2022 | 20:59h

The year in cardiovascular medicine 2021: diabetes and metabolic disorders – European Heart Journal

---

O ano de 2021 na medicina cardiovascular: insuficiência cardíaca e cardiomiopatias.

13 Jan, 2022 | 20:58h

The year in cardiovascular medicine 2021: heart failure and cardiomyopathies – European Heart Journal

---

O ano de 2021 na medicina cardiovascular: dislipidemia.

13 Jan, 2022 | 20:57h

The year in cardiovascular medicine 2021: dyslipidemia – European Heart Journal

---

O ano de 2021 na medicina cardiovascular: cardio-oncologia 2020–21.

13 Jan, 2022 | 20:56h

Year in cardiovascular medicine: cardio-oncology 2020–21 – European Heart Journal

---

O ano de 2021 na medicina cardiovascular: saúde digital e inovação.

13 Jan, 2022 | 20:55h

The year in cardiovascular medicine 2021: digital health and innovation – European Heart Journal

---